Indianapolis, IN, United States of America

Dennis C Thompson


Average Co-Inventor Count = 5.7

ph-index = 10

Forward Citations = 358(Granted Patents)


Company Filing History:


Years Active: 1992-2007

Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Mind of Dennis C. Thompson

Introduction

Dennis C. Thompson is an esteemed inventor based in Indianapolis, IN, known for his significant contributions to the field of pharmacology. With a remarkable portfolio of 17 patents, he has focused on developing novel compounds that address various psychiatric disorders. His innovative work highlights his dedication to improving mental health through scientific discovery.

Latest Patents

Among his latest patents are the groundbreaking "Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders." This invention presents a novel class of antipsychotic compounds of formula (I) that aims to enhance the therapeutic options available for individuals suffering from psychotic episodes. Additionally, he has developed serotonergic benzofurylpiperazines of Formula I, which have shown promise in treating patients with serotonin-related disorders.

Career Highlights

Throughout his esteemed career, Thompson has worked for Eli Lilly and Company, where he contributed to several innovative projects and helped to propel the company’s advancements in the pharmaceutical landscape. His dedication to research and development has made him a pivotal figure in the creation of transformative medications aimed at mental health.

Collaborations

Dennis C. Thompson has collaborated with talented individuals such as John M. Schaus and Joseph H. Krushinski, Jr. These partnerships have not only enriched his research but also led to significant developments in the understanding and treatment of psychiatric disorders. Working together with skilled colleagues has been instrumental in pushing the boundaries of pharmacological knowledge.

Conclusion

Overall, Dennis C. Thompson exemplifies the spirit of innovation within the pharmaceutical industry. His impressive number of patents and influential career reflect his commitment to advancing mental health treatment options. As he continues to innovate, the impact of his work will undoubtedly resonate with both the scientific community and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…